Severe autogenously fecal peritonitis in ageing Wistar rats. Response to intravenous meropenem.
Acta Cir Bras
; 29(9): 615-21, 2014 Sep.
Article
en En
| MEDLINE
| ID: mdl-25252209
ABSTRACT
PURPOSE:
To evaluate the treatment outcome of severe peritonitis in rats with increasing age.METHODS:
Thirty Wistar rats stratified in three groups group I - six month-old; group II - 12 month-old; and group III - 18 month-old, underwent autogenously fecal peritonitis (6 ml/kg rat), and were treated with intravenous meropenem. The survival animals were followed-up for 45 days. The variables were expressed by their mean and standard error of the mean (SEM). p<0.05 was used for rejecting the null hypothesis. The study was approved by the Ethics Committee.RESULTS:
There was a significant increase in the mortality and morbidity in elderly rats. Of interest, even among young survival rats presenting with severe residual abscesses both in the abdomen and thorax cavities, they present an almost normal life.CONCLUSIONS:
The treatment of severe autogenously fecal peritonitis with intravenous meropenem reached reasonable results in rats with six and twelve months of age, even considering residual abscesses on abdomen and thorax cavities. However, the great majority (80%) of elderly rats could not overcome the initial severe infectious challenge, proving that ageing is a very important risk factor for impairing immune response. Thus, sepsis remains a challenging situation, especially in elderly.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Peritonitis
/
Tienamicinas
/
Antibacterianos
Tipo de estudio:
Etiology_studies
/
Evaluation_studies
/
Risk_factors_studies
Aspecto:
Ethics
Límite:
Animals
Idioma:
En
Revista:
Acta Cir Bras
Año:
2014
Tipo del documento:
Article
País de afiliación:
Brasil